Duchene muscular dystrophy (DMD) is an inherited disorder of progressive muscular weakness and mostly affect males. The disease causes due to alteration of gene sequence coding for dystrophin protein present in the muscles. The symptoms of Duchene muscular dystrophy comprise weakness in muscles, intellectual disability and difficulty in walking and breathing. It also causes complications such as mental impairment, congestive heart failure, respiratory failure or pneumonia. The DMD cannot be cured, however, there are treatments available to lower the symptoms and signs. Gene therapy and stem cell therapy could be applied in the treatment of duchenne muscular dystrophy treatment.
Request To Sample PDF Brochure: https://www.coherentmarketinsights.com/insight/request-sample/898
Rise in the number of patients with DMD and increasing demand for its treatment is expected to propel growth of the global duchenne muscular dystrophy treatment market. For instance, in 2007, the Centers for Disease Control and prevention (CDC) reported DMD affects 349 males out of 2.37 million in the U.S. and in 2019, 349 patients were diagnosed with DMD.
Increasing investment in R&D to develop potential treatment for DMD is expected to augment growth of the global duchenne muscular dystrophy treatment market. For instance, US$75000 were invested in R&D by Muscular Dystrophy Association (MDA), U.S. for development of treatment for DMD. The association grants funds to more than 150 care centers, health care centers and hospitals in the U.S. as well as other countries.
Furthermore, factors such as continuous research on gene and stem cell therapy as well as exon skipping medications for DMD treatment are also likely to support growth of the duchenne muscular dystrophy treatment market
Late diagnosis of DMD and reduced seeking rate due to prognosis are expected to hamper growth of the global duchenne muscular dystrophy treatment market.
The global Duchenne muscular dystrophy (DMD) treatment market regionally divided into North America, Europe, Latin America, Middle East, Africa, and Asia Pacific.
Among regions, North America is expected to witness a strong growth in the Duchenne muscular dystrophy (DMD) treatment market, owing to well-established healthcare amenities rising number of DMD cases.
Europe is also expected to witness robust growth in the duchenne muscular dystrophy treatment market, owing to increasing cases of DMD. For instance, in 2009, the Center for Disease Control and Prevention (CDC), in North England estimated DMD or other muscular dystrophy affected 233 males out of 1.49 million.
Major players active in the duchenne muscular dystrophy (DMD) treatment market are, PTC Therapeutics, Sarepta Therapeutics, Pfizer Inc., SUMMIT Therapeutics Plc., BioMarin Pharmaceuticals Inc., Pharmacia & Upjohn LLC, and others.
Get PDF Brochure for More Insights –
The New Tactics of Duchenne Muscular Dystrophy (DMD) Treatment Market Report Offers a comprehensive market breakdown on the basis of value, volume, CAGR, and Y-o-Y growth. For business robust expansion, the report suggests new tools and technology development will drive to boom in the near future by 2028.
The Duchenne Muscular Dystrophy (DMD) Treatment Market report provides a comprehensive outline of Invention, Industry Requirement, technology and production analysis considering major factors such as revenue, investments and business growth.
This report for Duchenne Muscular Dystrophy (DMD) Treatment Market discovers diverse topics such as regional market scope, product-market various applications, market size according to a specific product, Market sales and revenue by region and more.
The report also tracks the industry news like mergers, acquisitions, and investments. Global Duchenne Muscular Dystrophy (DMD) Treatment Market Size (value and volume), market share, growth rate by types, applications, and combines both qualitative and quantitative methods to make micro and macro forecasts in different regions or countries.
According to this report Global Duchenne Muscular Dystrophy (DMD) Treatment Market will rise from Covid-19 crisis at moderate growth rate during 2021 to 2028. Duchenne Muscular Dystrophy (DMD) Treatment Market includes comprehensive information derived from depth study on Industry historical and forecast market data. Global Duchenne Muscular Dystrophy (DMD) Treatment Market Size to Expand moderately as the new developments in Duchenne Muscular Dystrophy (DMD) Treatment and Impact of COVID19 over the forecast period 2021 to 2028.
Duchenne Muscular Dystrophy (DMD) Treatment Market report provides depth analysis of the market impact and new opportunities created by the COVID19/CORONA Virus pandemic. Report covers Duchenne Muscular Dystrophy (DMD) Treatment Market report is helpful for strategists, marketers and senior management, And Key Players in Industry.
Reasons to Purchase this Report
• Current and future of global Duchenne Muscular Dystrophy (DMD) Treatment market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Table of Content
Global Duchenne Muscular Dystrophy (DMD) Treatment Market Research Report
Section 1: Global Duchenne Muscular Dystrophy (DMD) Treatment Industry Overview
Section 2: Global Economic Impact on Duchenne Muscular Dystrophy (DMD) Treatment Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Duchenne Muscular Dystrophy (DMD) Treatment Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027